Feds announce hemp CBD and THC Medicare coverage details (Newsletter: March 24, 2026)

*UT gov signs psychedelics bill; Canadian Conservative leader’s marijuana
stance; CO cannabis biz compliance checks; GA medical marijuana expansion*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Free to read (but not free to produce)!* We’re proud of our newsletter and
the reporting we publish at Marijuana Moment, and we’re happy to provide it
for free. But it takes a lot of work and resources to make this happen.

If you value Marijuana Moment, invest in our success on Patreon so we can
expand our coverage and more readers can benefit:
https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The Centers for Medicare & Medicaid Services released the first official
details about a pilot program to provide insurance coverage for
hemp-derived CBD products starting on April 1—confirming that up to 3
milligrams of THC will be allowed but noting that could change if a law
recently signed by President Donald Trump to recriminalize hemp THC
products takes effect without delay.

Utah Gov. Spencer Cox (R) signed a bill to support clinical trials into the
efficacy of psychedelic-assisted therapy for military veterans with serious
mental health conditions.

Canadian Conservative Party Leader Pierre Poilievre said using marijuana is
a “personal choice” when discussing the country’s legalization law with Joe
Rogan—even though he actually voted against the policy change that was led
by the Liberal Party.

A new report from the Colorado Marijuana Enforcement Division shows that
cannabis businesses had a 99 percent success rate in underage sales
compliance checks.

Georgia lawmakers passed a bill to expand medical cannabis access by
allowing vaping, adding new qualifying conditions and increasing THC
potency limits, sending it to the desk of Gov. Brian Kemp (R).

A New Mexico representative celebrated newly approved funding to provide
psilocybin therapy access for low-income patients, saying she’s considering
further legislation to make adjustments to or address any gaps in the
program next year.

About $95 million in Missouri marijuana revenue that is supposed to be
allocated to funding veterans services, public defenders and drug treatment
programs remains unspent.

*/ FEDERAL*

The U.S. Court of Appeals for the Ninth Circuit ruled that the federal
government must cover legal fees for an ayahuasca church following a
settlement.

U.S. Southern Command’s Gen. Francis L. Donovan said at a Senate hearing
that U.S. military strikes on suspected drug boats “aren’t the answer” to
the country’s drug problems.

The Drug Enforcement Administration touted a “surge enforcing a ban on
selling THC vape products to youth.”

Rep. Alexandria Ocasio-Cortez (D-NY) reportedly spent nearly $19,000 in
campaign cash last year on a psychiatrist who specializes in ketamine
therapy, though it’s not clear what the sessions consisted of or who
participated.

*/ STATES*

Nevada Gov. Joe Lombardo (R) appointed a new acting director for the
Cannabis Compliance Board.

The New Jersey Senate passed a bill to change deadlines for a phased-on ban
on intoxicating hemp products.

The Delaware House of Representatives passed a bill to clarify that rules
on distance between cannabis businesses only apply to dispensaries and not
production or wholesale facilities.

Colorado lawmakers are planning to file legislation to loosen restrictions
on hemp THC beverages.

California’s new top marijuana regulator discussed his plans for overseeing
the legal market.

The Virginia Cannabis Control Authority Board of Directors will meet on
April 8.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

The Boston, Massachusetts Cannabis Board will meet on Wednesday.

*/ INTERNATIONAL*

Japan’s Ministry of Health, Labour and Welfare listed cannabinol as a
“designated drug,” meaning that its manufacture, import, sale and use will
be banned as of June 1.

*/ SCIENCE & HEALTH*

A study found that “CBD-rich cannabis oil may reduce ADHD symptoms in
children with” autism spectrum disorder.

A review concluded that “CBD demonstrated strong positive effects in terms
of reducing symptoms associated with anxiety across various disorders
(generalized anxiety disorder, social anxiety disorder, and post-traumatic
stress disorder).”

*/ ADVOCACY, OPINION & ANALYSIS*

March For Our Lives sent a fundraising email stating its support for the
federal law banning gun possession by consumers of marijuana and other
illegal drugs that is currently before the U.S. Supreme Court..

*/ BUSINESS*

PharmaCann Inc. is closing a Denver, Colorado cultivation facility and
laying off 132 workers.

Canadian retailers sold C$466.1 million worth of legal marijuana products
in January.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

The post Feds announce hemp CBD and THC Medicare coverage details
(Newsletter: March 24, 2026) appeared first on Marijuana Moment.